Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lyxumia effects on brain activation in type 2 diabetes
NCT02745470Completed
- Sponsor
- Seoul National University Hospital
- Start
- Feb 2016
- Primary completion
- Dec 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of lixisenatide in type 2 diabetes mellitus (T2DM), sponsored by Seoul National University Hospital. Primary endpoint: Blood oxygenation level-dependent signal in hypothalamus. Started Feb 2016; status: completed.
02
Drugs
lixisenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02745470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02745470.